Endovascular Today6h
IceCure’s ProSense Cryoablation System’s Benefit-Risk Profile for Breast Cancer Indications Reviewed by FDA Panel
IceCure Medical Ltd. recently announced the FDA Medical Device Advisory Committee Panel’s favorable recommendation (voti ...
Endovascular Today3d
Bentley’s BeGraft and BeFlared Gain TÜV Certification as Bridging Stents for FEVAR
Bentley InnoMed GmbH announced it has been granted two TÜV certificates that extend indications for its stents in complex ...
Endovascular Today2d
Radial Access for SFA Intervention Using the IN.PACT™ 018 Drug-Coated Balloon With the SpiderFX™ Filter Wire
Robert L. Minor Jr, MD Interventional Cardiologist and Endovascular Specialist Director of Endovascular Interventions Limb ...
Endovascular Today12d
Healionics’ Stargraft AV Dialysis Access Device Receives FDA Breakthrough Device Designation
Healionics Corporation announced that its Stargraft arteriovenous (AV) graft for dialysis access has been granted ...
Endovascular Today6d
Simcere’s Sanbexin Before Thrombectomy Studied to Improve Outcomes After AIS in TASTE-2
Simcere Pharmaceuticals Group Ltd. recently announced that findings from the TASTE-2 clinical study have shown that the admini ...
Endovascular Today2d
The Next Game Changers for Radial Access in…
Opportunities to improve or optimize radial access for peripheral artery disease and embolization include additions and ...
Endovascular Today12d
Arsenal Medical’s EMBO-02 Study of NeoCast Liquid Embolic for cSDH Begins in Australia
Arsenal Medical announced the initiation of the EMBO-02 clinical study of its NeoCast liquid embolic to treat chronic ...
Endovascular Today6d
1-Year Data Presented From enVVeno’s VenoValve Pivotal Trial
November 20, 2024—enVVeno Medical Corporation announced 1-year data on all patients from SAVVE, the United States pivotal trial of the company&r ...
Endovascular Today2d
Patient-Centered Aortic Dissection Care
When I was invited by Endovascular Today to serve as Guest Chief Medical Editor of an edition on aortic dissection (AD), I ...
Endovascular Today6d
Xeltis Receives FDA Breakthrough Device Designation for aXess Vascular Access Conduit, Begins US Pivotal Trial
Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular acce ...
Endovascular Today5d
Solaris Endovascular, Inc. Launched in the United States
Solaris Endovascular, Inc. recently announced the formation of the company, which will develop solutions for dialysis access i ...
Endovascular Today12d
R3 Vascular Receives IDE Approval for ELITE-BTK Pivotal Trial of Magnitude Scaffold
R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE) approval to initiate the compa ...